Annual SGA
$15.65 M
+$7.77 M+98.55%
September 1, 2024
Summary
- As of February 7, 2025, CTOR annual SGA is $15.65 million, with the most recent change of +$7.77 million (+98.55%) on September 1, 2024.
- During the last 3 years, CTOR annual SGA has risen by +$14.22 million (+995.24%).
- CTOR annual SGA is now at all-time high.
Performance
CTOR SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CTOR Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +98.5% | - | - |
| 3 y3 years | +995.2% | - | - |
| 5 y5 years | +995.2% | - | - |
CTOR Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +995.2% | ||||
| 5 y | 5-year | at high | +995.2% | ||||
| alltime | all time | at high | +995.2% |
Citius Oncology Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | $15.65 M(+98.6%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | $7.88 M(+451.6%) | - | - |
| Sep 2022 | $1.43 M | - | - |
FAQ
- What is Citius Oncology annual SGA?
- What is the all time high annual SGA for Citius Oncology?
- What is Citius Oncology annual SGA year-on-year change?
What is Citius Oncology annual SGA?
The current annual SGA of CTOR is $15.65 M
What is the all time high annual SGA for Citius Oncology?
Citius Oncology all-time high annual SGA is $15.65 M
What is Citius Oncology annual SGA year-on-year change?
Over the past year, CTOR annual SGA has changed by +$7.77 M (+98.55%)